Navigation Links
Doctors needed urgently in Gujarat

AHMEDABAD

This appeal from Medindia.net is addressed to all doctors to help at this hour of crisis in making the efforts of their fellow doctors at Gujarat more fruitful. Doctors can contact the above-mentioned numbers anytime. At this moment every person’s work will make a difference. Apart from this there are also various other things that common people can do. People can donate used clothes; footwear, beddings and sheets, utensils, provision and anything that they feel will help their brothers and sisters of Gujarat.

The other help line numbers are:

Railway 24 hour help line - 044- 535 8164 and 079- 211 1413

Earth quake control room – 657 8369

Birla AT&T cellular help line 98240- 1234

Gandhinagar – (02712) 51911/51912/51913/51914/51915/51916/51917

'"/>




Page: 1 2 3 4

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors operate upon patients in candlelight- latest from the quake scene
3. Doctors at risk- the ugly side of the noble profession
4. Doctors advice early anemia tests
5. Emphasis to ban Drugs ads by Doctors
6. Doctors not to accept gifts from drug companies
7. Gene testing kit specific for Doctors
8. Doctors warned of fluoride toxicity
9. Doctors decisions are affected by fear of lawsuits- says a study
10. Bihar High Court Intervenes To End Doctors Strike
11. Doctors Warned by IMA Against Treating Maoist from Nepal
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Doctors needed urgently Gujarat

Breaking Medicine Technology:Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4